Pharmacotherapy Review of Narcolepsy

Narcolepsy can exact a devastating toll on the (probably underdiagnosed) patient. Treatment can range from lifestyle to medications. Join host, Geoff Wall, as he explores a new oral orexin agonist for the treatment of narcolepsy. The GameChangerNarcolepsy is more common than assumed. Current treatments include stimulant agents but a new class of orexin agonists may be effective, yet have safety concerns. HostGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint Health ReferenceDauvilliers Y, Mignot E, Del Río Villegas R, et al. Oral Orexin Receptor 2 Agonist in Narcolepsy Type 1. N Engl J Med. 2023 Jul 27;389(4):309-321. doi: 10.1056/NEJMoa2301940. PMID: 37494485.https://www.nejm.org/doi/full/10.1056/NEJMoa2301940?query=featured_home Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe the manifestations, prevalence, and types of narcolepsy and associated symptoms. 2. Discuss the benefits and risks of orexin drugs in treatment of narcolepsy.0.05 CEU/0.5 HrUAN: 0107-0000-23-292-H01-PInitial release date: 8/28/2023Expiration date: 8/28/2024Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram